Sleep disturbances are common in patients with chronic obstructive pulmonary disease (COPD), but little is known about the prescription of hypnotics for them. 1 4 In order to assess it, we performed a chart review using medical records of 109 sequential patients with COPD who were admitted to our hospital between January 1998 and December 2002. The patients ranged in age from 54 to 90 years, with a median age of 72. Median and interquartile range of forced expiratory volume in one second (FEVI) and diffusing capacity for carbon monoxide (DLCO) were 0.76 x 10-3m3 (0.59-1.00 x 10-3 m3), and 48.3% (34.2-62.6%), respectively. Among the 109 patients, 37 (33.9%) patients complained of sleep disturbance and had hypnotics for one week or more. In 27 (73.0%) of the 37 patients, shortor middle-acting benzodiazepines were prescribed.
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In blood gas analysis before the use of hypnotics, all of the 37 patients who had hypnotics had partial pressure of oxygen (PaO2)> 8.0 kPa and partial pressure of carbon dioxide (PaCO2) < 8.0 kPa. PaO2 in the 37 patients who had hypnotics (median 10.2 kPa, interquartile range 9.0-11.0 kPa) was higher than that in 72 patients who did not have hypnotics (median 9.5 kPa, interquartile range 8.7-10.4 kPa) (P = 0.0387, Mann-Whitney test). However, no statistical differences were observed between the patients who received hypnotics and those who did not with regard to age (more than 70 years or less, P = 0.3181), gender (P = 0.1803, chi-square test), PaCO2 (P = 0.1207), DLCO (P = 0.0949), and FEVI (P = 0.7538), respectively. No episodes of CO2 narcosis due to the prescription of hypnotics were described in medical records of the 37 COPD patients with hypnotics. Other adverse effects such as nocturnal hypoxemia, worsening of sleep apnea, and worsening of daytime oxygenation were not observed.
Much attention has been given to the adverse effects of hypnotics for COPD patients; however, little is known about the clinical information to prevent physicians from prescribing hypnotics for COPD patients. In this retrospective study, hypnotics were prescribed only in patients with both PaO2> 8.0 kPa and PaCO2< 8.0kPa. In addition, we showed that PaO2 in patients who had hypnotics was higher than that in patients who did not have hypnotics. Although careful individualization of medication is appropriate, clinical guideline for the prescribing of hypnotics for COPD patients will be required.
